Merosya 7 Tablet
Prescription Required
Product introduction
Merosya 7 Tablet is a medicine used in the treatment of relapsing forms of multiple sclerosis (MS). It works by limiting the function of specific immune cells that cause nerve damage in multiple sclerosis. This way it prevents relapse as well as reduces the progression of the disease.
Merosya 7 Tablet
Merosya 7 Tablet
Uses of Merosya Tablet
- Relapsing forms of multiple sclerosis (MS)
Benefits of Merosya Tablet
In Relapsing forms of multiple sclerosis (MS)
Multiple sclerosis (MS) is a disease of the brain and spinal cord in which a person’s own immune system attacks the protective sheath (called myelin) of the nerves. This leads to symptoms such as vision loss, pain, fatigue and improper coordination. Merosya 7 Tablet helps to suppress the body’s immune system, thereby preventing returning of symptoms (relapse) as well as reducing the progression of the disease. It reduces the inflammation of the damaged nerves, prevents further damage and stabilises your immune system. Follow your doctor’s instructions carefully to get the best results.
Side effects of Merosya Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Merosya
- Increased liver enzymes
- Hair loss
- Diarrhea
- Nausea
- Abnormal liver function tests
- Paresthesia (tingling or pricking sensation)
How to use Merosya Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Merosya 7 Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Merosya Tablet works
Merosya 7 Tablet is an immunomodulatory medication. It works by limiting the function of specific immune cells (T and B cells) that cause nerve damage in multiple sclerosis.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Merosya 7 Tablet. Please consult your doctor.
Pregnancy
UNSAFE
Merosya 7 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
CONSULT YOUR DOCTOR
Merosya 7 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Merosya 7 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Merosya 7 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Merosya 7 Tablet may be needed. Please consult your doctor.
Liver
UNSAFE
Merosya 7 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Merosya 7 Tablet
₹60.0/Tablet
Teru MS 7mg Tablet
MSN Laboratories
₹65.64/tablet
9% costlier
Scleteri 7mg Tablet
Sun Pharmaceutical Industries Ltd
₹30/tablet
50% cheaper
Quick tips
- Merosya 7 Tablet helps treat multiple sclerosis.
- Take it with food to avoid an upset stomach.
- Do not chew, crush or break the tablets as they have a special coating to help prevent irritation of your stomach.
- Do not consume alcohol while taking this medicine as it may worsen the side effects.
- Your doctor may get regular blood and urine tests done to monitor your blood cells, kidney and liver function during treatment with this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.
- Do not take Merosya 7 Tablet if you are pregnant or breastfeeding. Use a reliable contraceptive method to prevent pregnancy.
Fact Box
Chemical Class
Trifluoromethylbenzene Derivative
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Immunomodulator- Multiple sclerosis (oral)
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1333.
- MedlinePlus. Teriflunomide. [Accessed 22 Jan. 2019] (online) Available from:
- Teriflunomide.Cambridge, MA: Sanofi; 2012. [Accessed 22 Mar 2019] (online) Available from:
- Teriflunomide. Compiègne, France: Sanofi Winthrop Industrie; 2019. [Accessed 22 Mar 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Teriflunomide. [Updated 2018 Dec 3]. [Accessed 20 Feb. 2020] (online) Available from:
Marketer details
Name: Intas Pharmaceuticals Ltd
Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
63 people viewed this recentlyMRP
₹600
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me